Skip to main content
. 2020 Jun 17;14:577. doi: 10.3389/fnins.2020.00577

FIGURE 3.

FIGURE 3

Effects of LRRK2 and α-synuclein on the autophagy-lysosomal pathway. This is an example of how LRRK2 and α-synuclein can have convergent mechanisms with both affecting the autophagy-lysosomal system but each acting on different targets within the system. Mutant or aggregated α-synuclein can block CMA and autophagosome formation, while mutant LRRK2 can also block CMA, disrupt mitophagy or delay autophagosome trafficking.